-
Joanne Nova of Australia goes on…
Petition the Australian TGA to consider cheap drugs as well as expensive ones!
Please share and sign. Closing tonight!
Some drugs are apparently too cheap to approve.
They want us to trust them, but if they won’t investigate cheap options, they don’t appear to have our interests at heart. Who do they serve?
Even if a long-used safe cheap drug reduced infections or deaths by 10% the cost-benefits of using it are obvious for everyone (except the companies that sell expensive competing products). The studies we have suggest one antiviral (and there are many others) could reduce infections by 86% and deaths by 50% or more. The antiviral successes against Covid in India, Mexico and Peru [TheRealRestoreInc. draws your attention to these countries using ivermectin] are there for all to see. If antivirals were being used in Sydney perhaps they could have halved the Ro (or more), slowed the spread, saved lives and businesses and shortened the lockdown?
Which brings us to the awkward questions that almost no one seems to be even asking: Why aren’t cheap low risk drugs already well tested ten times over? Why aren’t the TGA and Health Ministry urgently working to fix obvious clinical vitamin deficiencies like D3? Where is the ABC and our publicly funded institutions and our academics? Isn’t the point of publicly funded universities […]